Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Korea SE
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

Hanall Biopharma Co Ltd

+ Add to Watchlist

009420:KS

4,780 KRW 10 0.21%

As of 01:26:21 ET on 03/06/2015.

Company Profile for Hanall Biopharma Co Ltd (009420)

HANALL BIOPHARMA CO., LTD. manufactures prescription drugs for hospitals. The Company specializes in making oral and non-oral antibiotics and amino-acid infusions.

Contact Information

Hanall Biopharma Co Ltd

400-1 Sangseo-dong
Daedeok-gu
Daejeon, 306-120
Korea, Republic of (South)
Phone: 82-42-932-5997
Fax: 82-42-932-6427

Key Executives for Hanall Biopharma Co Ltd (009420)

Kim Sung-WookPresident/CEO/Co-Rep DirectorPark Seung-GukCo-Rep Director
Jo Nam-YongSenior Managing DirectorLee Han-SuManaging Director
Kim Seong-JinManaging DirectorYoo Sang-HeeManaging Director
Kim Hong-WooManaging DirectorLee Sun-ImExecutive Director
Kim Seong-MinExecutive DirectorLee Geun-WooExecutive Director
Lee Moon-JaeExecutive DirectorSon Bum-KyuExecutive Director
Kim Min-JungExecutive Director

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil